Trends in Isolated and Combined Aortic Valve Replacement for Severe Aortic Stenosis in Patients Younger Than 65 Years
In this multicenter study, there is a consistent increase in TAVR use in patients <65 years old with preferential TAVR utilization in patients with higher comorbidities and risk. While approximately 50% of younger patients with isolated AS are receiving TAVR in recent study years, the overall utilization of TAVR in the broader group of patients with both isolated and combined AS remains approximately 25% of the overall AVR cohort.
Authors
- Rony N. Lahoud (ORCID: https://orcid.org/0000-0002-8715-2095)
- James T. DeVries (ORCID: https://orcid.org/0000-0003-3920-5831)
- Harold L. Dauerman (ORCID: https://orcid.org/0000-0003-2414-2612)
- Frank P. Ittleman
- Ansar Hassan (ORCID: https://orcid.org/0000-0001-6865-2679)
- James M. Flynn (ORCID: https://orcid.org/0000-0003-1126-1794)
- Hsiang-Ching Huang
- Tanush Gupta (ORCID: https://orcid.org/0000-0002-2047-2625)
- David Butzel
- Cathy S. Ross (ORCID: https://orcid.org/0000-0002-6039-3673)
- Michael N. Young (ORCID: https://orcid.org/0000-0003-3178-8702)
Institutions
- Dartmouth–Hitchcock Medical Center (US)
- Catholic Medical Center (US)
- Maine Medical Center (US)
- University of Vermont Medical Center (US)
- Maine Medical Center (US)
Publication Details
- Journal
- Structural Heart
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1016/j.shj.2025.100684
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Boston Scientific Corporation
- Medtronic